APRT
Adenine phosphoribosyltransferase
Also known as: APT_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P07741
- Gene
- APRT
- Ensembl
- ENSG00000198931
- Chromosome
- 16
- Canonical length
- 180 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Adenine phosphoribosyltransferase belongs to the purine/pyrimidine phosphoribosyltransferase family. A conserved feature of this gene is the distribution of CpG dinucleotides. This enzyme catalyzes the formation of AMP and inorganic pyrophosphate from adenine and 5-phosphoribosyl-1-pyrophosphate (PRPP). It also produces adenine as a by-product of the polyamine biosynthesis pathway. A homozygous deficiency in this enzyme causes 2,8-dihydroxyadenine urolithiasis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
180 residues, UniProt reviewed canonical sequence.
>P07741|APRT
1 MADSELQLVE QRIRSFPDFP TPGVVFRDIS PVLKDPASFR AAIGLLARHL KATHGGRIDY
61 IAGLDSRGFL FGPSLAQELG LGCVLIRKRG KLPGPTLWAS YSLEYGKAEL EIQKDALEPG
121 QRVVVVDDLL ATGGTMNAAC ELLGRLQAEV LECVSLVELT SLKGREKLAP VPFFSLLQYELocalizationUniProt · AlphaFold · HPA
Whether an antibody against APRT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 233 nTPM
Expression across tissuesHPA
Tissue
- skin: 233 nTPM
- esophagus: 226 nTPM
- liver: 187 nTPM
- pancreas: 165 nTPM
- adrenal gland: 157 nTPM
- vagina: 148 nTPM
Single-cell type
- esophageal suprabasal cells: 1,172 nCPM
- esophageal basal cells: 848 nCPM
- suprabasal keratinocytes: 598 nCPM
- esophageal apical cells: 506 nCPM
- megakaryocytes: 495 nCPM
- extravillous trophoblasts: 470 nCPM
Immune cell
- total PBMC: 998 nTPM
- plasmacytoid DC: 733 nTPM
- MAIT T-cell: 633 nTPM
- memory CD4 T-cell: 614 nTPM
- myeloid DC: 563 nTPM
- naive CD4 T-cell: 559 nTPM
Brain region
- choroid plexus: 47 nTPM
- thalamus: 39 nTPM
- white matter: 39 nTPM
- spinal cord: 35 nTPM
- medulla oblongata: 33 nTPM
- hypothalamus: 32 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about APRT.
Disease | AllUniProt
Conditions APRT is implicated in, by any mechanism.
- Adenine phosphoribosyltransferase deficiency (APRTD) MIM:614723
Disease | GeneticClinVar
78 pathogenic / likely-pathogenic of 209 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Adenine phosphoribosyltransferase deficiency
- See cases
- APRT deficiency, Japanese type
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.96
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.24
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- AMP binding
- adenine binding
- adenine phosphoribosyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Phosphoribosyltransferase domain
- Phosphoribosyltransferase-like
- Phosphoribosyl transferase domain
- Adenine phosphoribosyl transferase
- Uracil phosphoribosyltransferase/Adenine phosphoribosyltransferase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads APRT as an antibody target. Whether an autoantibody or antibody against APRT could matter depends on whether native APRT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
APRT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label APRT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...